HCWB · HCW Biologics Inc. · Analyst Estimates
$1.64
-0.04 (-2.38%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company believes that substantial doubt exists regarding its ability to continue as a going concern for at least 12 months from the date of issuance of the Company's condensed financial statements, without additional funding or financial support. After considering management's plan for financing and funds raised that are probable to occur within one year, as well as that the Company expects to continue to incur losses from operations for the foreseeable future, management concluded that the substantial doubt that existed in its going concern analysis as of June 30, 2026 was not alleviated.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.54M
Shares
1.84M
Volume · Oct 5
83.29K
Avg daily vol (3M)
371.87K
Analyst Estimates
Compare analyst forecasts for HCW Biologics Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-03 22:14 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-28.31999
|
-28.31999
|
-28.31999
|
— |
-2.88
|
-2.88
|
-2.88
|
-2.88
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
6679000
|
6679000
|
6679000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-6.3
|
-6.3
|
-6.3
|
— |
-2.64
|
-2.64
|
-2.64
|
-2.64
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-8.1
|
-8.1
|
-8.1
|
— |
-1.08
|
-1.08
|
-1.08
|
-1.08
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-8.34
|
-8.34
|
-8.34
|
— |
-1.08
|
-1.08
|
-1.08
|
-1.08
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — | — | — | — | — |